Preventing aspiration events in hospital using prophylactic antiemetics: A systematic review and meta-analysis
Tworek, K. B.; Giovannoni, M.; Kung, J.; Lau, V.
Show abstract
Introduction Aspiration events in hospitalized adults are common and linked to substantial morbidity, mortality, and healthcare burden. While antiemetics have been studied for aspiration prevention in specific settings, evidence for their broader preventive use in hospitalized adults is limited. We conducted a systematic review and meta-analysis to evaluate the effect of prophylactic scheduled antiemetics on aspiration events in adult inpatients. Methods: Ovid MEDLINE, Ovid Embase, CINAHL, and Cochrane Library (via Wiley) were searched in May 2025. We included randomized controlled trials (RCTs) and observational studies assessing prophylactic scheduled antiemetic use in hospitalized adults, with aspiration events as the primary outcome. Secondary outcomes were aspiration pneumonia, hospital length of stay, increased oxygen requirement, ICU admission, and mortality. Two investigators screened and independently extracted data in duplicate using standardized data collection forms. Extracted information included study characteristics, patient demographics and clinical characteristics, interventions, and outcomes. Results: Three RCTs met inclusion criteria (n = 515 patients; 237 antiemetic, 278 placebo). Pooled analysis of two RCTs demonstrated an 88% relative risk [RR] reduction of aspiration events; (2.8% [3/106] prophylactic antiemetic vs 27.9% [29/104] placebo; RR = 0.12, 95% confidence intervals [CI]: 0.02-0.73, p <0.0001, low certainty) in the antiemetic group. Pneumonia rates were also lower in the antiemetic group although they did not reach statistical significance (16.5% vs 32.4%; RR 0.44, 95% CI 0.15-1.28, P = 0.13, low certainty). ICU admission rates were lower in the antiemetic group (2.6% [2/76]) vs. placebo (23% [17/74]); RR = 0.11, 95% CI: 0.03-0.48, p=0.003, very low certainty). Mortality was similar between groups (35.0% vs 38.1%; RR 1.02, 95% CI: 0.84-1.24, P = 0.85, low certainty). No adverse events were reported among all studies. Conclusion: Prophylactic scheduled antiemetics were associated with a significant reduction in aspiration and ICU admission. There was a non-significant but favorable trend towards reduction of pneumonia among hospitalized adults. Larger, high-quality trials are needed to clarify their role in aspiration prevention.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- The Effect of Famotidine on Hospitalized Patients with COVID-19: a Systematic Review and Meta-analysis 94%
- Colchicine use in patients with COVID-19: a systematic review and meta-analysis 94%
- Prevalence and outcomes of co-infection and super-infection with SARS-CoV-2 and other pathogens: A Systematic Review and Meta-analysis 92%
Similar papers in this journal
- Rates of serious clinical outcomes in survivors of hospitalisation with COVID-19: a descriptive cohort study within the OpenSAFELY platform 88%
- A Rapid Review and Meta-Analysis of the Asymptomatic Proportion of PCR-Confirmed SARS-CoV-2 Infections in Community Settings 86%
- Sensitivity of RT-PCR testing of upper respiratory tract samples for SARS-CoV-2 in hospitalised patients: a retrospective cohort study. 86%
Similar papers in this journal
- Criteria to Achieve Safe Antimicrobial Intravenous-to-Oral Switch in Hospitalised Adult Populations: A Systematic Rapid Review 92%
- The DEXACELL Trial; a protocol for a pragmatic, multicentre, double-blind, placebo-controlled, randomised, parallel group, phase 3 superiority trial to assess the effectiveness and cost-effectiveness of DEXAmethasone as an adjunctive therapy for the management of CELLulitis in adults presenting to urgent secondary care in the UK 92%
- Optimal duration of antibiotic treatment for community-acquired pneumonia in adults: a systematic review and duration-effect meta-analysis 92%
Similar papers in this journal
- Adrenaline (epinephrine) compared to selective beta-2-agonist in adults or children with acute asthma: a systematic review and meta-analysis 93%
- A systematic review of Anakinra, Sarilumab, Siltuximab with meta-analysis of Tocilizumab for Covid-19 90%
- Early Lenzilumab Treatment Of COVID-19 Patients Using C-Reactive Protein As A Biomarker Improves Efficacy: Results From The Phase 3 ‘Live-Air’ Trial 89%
Similar papers in this journal
- Antivirals for post-exposure prophylaxis of influenza: a systematic review and network meta-analysis 91%
- Antivirals for treatment of severe influenza: a systematic review and network meta-analysis of randomized controlled trials 90%
- Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study 89%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.